TELADOC HEALTH, INC.

(TDOC)
  Report
Delayed Nyse  -  04:00 2022-08-12 pm EDT
40.32 USD   +6.13%
08/12Teladoc Shares Rise After DA Davidson Begins Coverage at Buy
MT
08/12There are two ways to see inflation data
MS
08/12ANALYST RECOMMENDATIONS : Walt Disney, Salesforce, ServiceNow, Cigna, Equinix...
MS
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Teladoc Health, Inc. acquired Consultant Connect Limited for $56.3 million.

05/02/2021 | 06:00pm EDT

Teladoc Health, Inc. (NYSE:TDOC) acquired Consultant Connect Limited for $56.3 million on January 4, 2021. As per terms of transaction, $55.9 million was paid in the three months ended March 31, 2021 Teladoc Health, Inc. (NYSE:TDOC) completed the acquisition of Consultant Connect Limited on January 4, 2021.


© S&P Capital IQ 2021
All news about TELADOC HEALTH, INC.
08/12Teladoc Shares Rise After DA Davidson Begins Coverage at Buy
MT
08/12There are two ways to see inflation data
MS
08/12ANALYST RECOMMENDATIONS : Walt Disney, Salesforce, ServiceNow, Cigna, Equinix...
MS
08/12DA Davidson Starts Teladoc at Buy With $45 Price Target
MT
08/10Teladoc Adds At-Home Blood Sugar Test to Livongo Program; Shares Rise
MT
08/10Teladoc Health Makes A1C Testing Easier for Members with Diabetes
GL
08/10Teladoc Health Makes A1C Testing Easier for Members with Diabetes
AQ
08/10Teladoc Health Makes A1C Testing Easier for Members with Diabetes
CI
08/03TELADOC HEALTH, INC. Management's Discussion and Analysis of Financial Condition and R..
AQ
08/02TELADOC HEALTH 72 HOUR DEADLINE ALER : Former Louisiana Attorney General and Kahn Swick & ..
BU
More news
Analyst Recommendations on TELADOC HEALTH, INC.
More recommendations
Financials (USD)
Sales 2022 2 409 M - -
Net income 2022 -9 737 M - -
Net Debt 2022 627 M - -
P/E ratio 2022 -0,68x
Yield 2022 -
Capitalization 6 518 M 6 518 M -
EV / Sales 2022 2,97x
EV / Sales 2023 2,50x
Nbr of Employees 4 718
Free-Float 98,7%
Chart TELADOC HEALTH, INC.
Duration : Period :
Teladoc Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TELADOC HEALTH, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 29
Last Close Price 40,32 $
Average target price 40,65 $
Spread / Average Target 0,82%
EPS Revisions
Managers and Directors
Jason N. Gorevic Chief Executive Officer & Director
Mala Murthy Chief Financial Officer
David B. Snow Non-Executive Chairman
Jeff Nadler Chief Information Officer
Yulun Wang Head-Research & Development